June 13, 2011
I am pleased to announce the availability of individual cases from Building the Case for Biotechnology Management Case Studies in Science, Laws, Regulations, Politics, and Business in digital and printed formats. The casebook, which was recently reviewed in Nature Biotechnology, features 22 case studies in science; law, regulation, politics; and business, and a foreword by [...]
Read the full article →
December 21, 2010
Many biotechnology entrepreneurs favorably look back at times when financing and regulatory approval were easier to obtain. While future periods of investor exuberance may return, it is better to see these as market aberrations. In periods of investor exuberance companies have been pushed to focus on low-probability, high-return, objectives such as approval and successful marketing [...]
Read the full article →